Hirtle Callaghan & Co’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-23,066
Closed -$2.14M 45
2019
Q2
$2.14M Buy
+23,066
New +$2.07M 0.17% 20
2018
Q1
Sell
-345
Closed -$29K 138
2017
Q4
$29K Hold
345
﹤0.01% 108
2017
Q3
$28K Hold
345
﹤0.01% 128
2017
Q2
$27K Hold
345
﹤0.01% 107
2017
Q1
$26K Buy
+345
New +$25.1K ﹤0.01% 133

Other funds holding XLV

Hirtle Callaghan & Co's XLV Position: Q3 2019 in Review

Hirtle Callaghan & Co sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q3 2019, closing a stake of 23,066 shares — an estimated $2.14M sold.

Hirtle Callaghan & Co first reported a position in XLV in Q1 2017 and held it in 5 quarters. The position peaked at $2.14M in Q2 2019. 841 funds tracked by Wall St. Rank hold XLV as of Q3 2019.

  • Hirtle Callaghan & Co reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q3 2019 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 23,066 State Street Health Care Select Sector SPDR ETF shares in Q3 2019, an estimated $2.14M.
  • Hirtle Callaghan & Co first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2017 and held it in 5 quarters.
  • Hirtle Callaghan & Co's State Street Health Care Select Sector SPDR ETF position peaked at $2.14M in Q2 2019.
  • 841 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2019, filed 31 Oct 2019.